Fully automated high-throughput platform allows researchers to generate high-quality data on genetic and epigenetic variants for cancer and other common diseases LEXINGTON, Mass. – November 15, 2012 – RainDance Technologies, Inc., the Digital Biology™ Company, today announced that the
Fully automated high-throughput platform enables researchers to rapidly generate high-quality data related to the molecular mechanisms involved in disease LEXINGTON, Mass. and SAN FRANCISCO – November 8, 2012 – RainDance Technologies, Inc., the Digital Biology™ Company, today announce
RainDance Technologies® is making complex genetics simple. The company’s ultra-sensitive genomic tools enable research of novel non-invasive liquid biopsy applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases. Major research institutions and laboratories around the world rely on the performance of RainDance systems. Based outside Boston, Massachusetts, the company supports customers using RainDrop® Digital PCR, as well as the ThunderStorm® and ThunderBolts™ Next-Generation Sequencing Enrichment Systems through its international sales and service operations, as well as a global network of distributors and commercial service providers. Both technology platforms have been recognized by The Scientist as Top 10 Innovations with the RainDrop System winning the award in 2014 and the ThunderStorm System winning the award in 2011.